Citi Reiterates Buy Rating on Torrent Pharma (TRP:IN)
Tweet Send to a Friend
Citi analyst Vivek Agrawal reiterated a Buy rating and INR3,000.00 price target on Torrent Pharma (TRP:IN).The analyst comments: "TORP reported ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




